Weight loss can be a challenging journey, especially when seeking effective and accessible solutions. The rise in popularity ...

Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised ...

Here are eight things to know from the updated guidelines: GLP-1s are recommended to lower the risk of cardiovascular disease and stroke in patients with diabetes or cardiovascular disease, or at a ...

With weight loss injectables like Ozempic and Mounjaro taking the world by storm, the diet industry is seemingly being left ...

GLP-1 drugs such as Novo Nordisk's Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Cedars-Sinai experts believe the study's findings can play a crucial role in developing healthcare policies that promote ...

Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...

New guidelines for stroke prevention from the American Stroke Association highlight unique risk factors for women and how ...

The American Stroke Association has released new guidelines to lower your risk of stroke. Here’s what the organization ...

Novo Nordisk has nominated semaglutide for inclusion in the FDA’s Demonstrable Difficulties for Compounding list, which ...